<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Flow cytometry (FCM) is being increasingly evaluated for the diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We employed multiple FCM approaches to assess <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Five-color FCM, <z:mp ids='MP_0000002'>morphology</z:mp> blind, was done on bone marrow aspirates of 57 suspected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 31 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="3" pm="."><plain>Maturation pattern, quantitative FCM for low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> that awards FCM score, and expression of selected antigens on erythroid cells and CD34(+) blasts were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>FCM results were correlated with clinical and laboratory workup </plain></SENT>
<SENT sid="5" pm="."><plain>Patients (n = 57) included proven <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 14), suspected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 13), and non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 30) </plain></SENT>
<SENT sid="6" pm="."><plain>By pattern-based approach, <z:hpo ids='HP_0000001'>all</z:hpo> proven cases were FCM positive </plain></SENT>
<SENT sid="7" pm="."><plain>In suspected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, 11 (84.61 %) were positive including <z:mp ids='MP_0000002'>morphology</z:mp>-negative cases, and two (15.38 %) were intermediate </plain></SENT>
<SENT sid="8" pm="."><plain>In non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases, 27 of 30 (90 %) were FCM negative, 2 of 30 (6.67 %) intermediate, and 1 of 30 (3.33 %) a hematinic-responsive case, positive </plain></SENT>
<SENT sid="9" pm="."><plain>Quantitative parameters that characterized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> included FCM score of &gt;3, percentage CD34(+) B cells, and expression of CD11b, CD15, and CD56 on myeloblasts </plain></SENT>
<SENT sid="10" pm="."><plain>CD71 MFI on CD235a(+) erythroblasts and CD38 MFI on myeloblasts were significantly lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>The former was present in FCM-intermediate suspected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> but not FCM-intermediate non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases </plain></SENT>
<SENT sid="12" pm="."><plain>Used in the overall clinical context, both maturation pattern recognition and quantitative approaches, the latter for low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, are sensitive methods of diagnosing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, including cases negative by <z:mp ids='MP_0000002'>morphology</z:mp> and cytogenetics, especially if combined with evaluation of selected antigens, CD71 on CD235a(+) cells and CD38 on CD34(+) cells </plain></SENT>
<SENT sid="13" pm="."><plain>The value of FCM in <z:mp ids='MP_0000002'>morphology</z:mp>-negative cases needs better definition of specificity through more extensive evaluation of secondary dyspoiesis </plain></SENT>
</text></document>